Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yasuhiro Katagiri is active.

Publication


Featured researches published by Yasuhiro Katagiri.


Nature Neuroscience | 2012

NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans

Travis L. Dickendesher; Katherine T. Baldwin; Yevgeniya A. Mironova; Yoshiki Koriyama; Stephen J. Raiker; Kim L. Askew; Andrew Wood; Cédric G. Geoffroy; Binhai Zheng; Claire D. Liepmann; Yasuhiro Katagiri; Larry I. Benowitz; Herbert M. Geller; Roman J. Giger

In the adult mammalian CNS, chondroitin sulfate proteoglycans (CSPGs) and myelin-associated inhibitors (MAIs) stabilize neuronal structure and restrict compensatory sprouting following injury. The Nogo receptor family members NgR1 and NgR2 bind to MAIs and have been implicated in neuronal inhibition. We found that NgR1 and NgR3 bind with high affinity to the glycosaminoglycan moiety of proteoglycans and participate in CSPG inhibition in cultured neurons. Nogo receptor triple mutants (Ngr1−/−; Ngr2−/−; Ngr3−/−; which are also known as Rtn4r, Rtn4rl2 and Rtn4rl1, respectively), but not single mutants, showed enhanced axonal regeneration following retro-orbital optic nerve crush injury. The combined loss of Ngr1 and Ngr3 (Ngr1−/−; Ngr3−/−), but not Ngr1 and Ngr2 (Ngr1−/−; Ngr2−/−), was sufficient to mimic the triple mutant regeneration phenotype. Regeneration in Ngr1−/−; Ngr3−/− mice was further enhanced by simultaneous ablation of Rptpσ (also known as Ptprs), a known CSPG receptor. Collectively, our results identify NgR1 and NgR3 as CSPG receptors, suggest that there is functional redundancy among CSPG receptors, and provide evidence for shared mechanisms of MAI and CSPG inhibition.


Nature Cell Biology | 2000

Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B.

Yasuhiro Katagiri; Kazuyo Takeda; Zu-Xi Yu; Victor J. Ferrans; Keiko Ozato; Gordon Guroff

The retinoid–X receptor (RXR) regulates multiple hormonal pathways through heterodimerization with nuclear receptors such as the all-trans retinoic acid receptor (RAR). The orphan nuclear receptor NGFI-B (also called Nur77) can heterodimerize with RXR. Here we show that nerve growth factor (NGF) induces the phosphorylation of Ser 105 of NGFI-B in PC12 phaeochromocytoma cells, resulting in translocation of the NGFI-B–RXR heterodimer complex out of the nucleus using nuclear export signals within NGFI-B. As a consequence of the redistribution of RXR, the transcriptional activity of RXR–RAR is reduced. NGFI-B-mediated nuclear export of receptors may serve as a mechanism for crosstalk between NGF and retinoid pathways.


Journal of Cell Science | 2008

Chondroitin-4-sulfation negatively regulates axonal guidance and growth

Hang Wang; Yasuhiro Katagiri; Thomas E. McCann; Edward J. Unsworth; Paul Goldsmith; Zu Xi Yu; Fei Tan; Lizzie Y. Santiago; Edward M. Mills; Yu Wang; Aviva J. Symes; Herbert M. Geller

Glycosaminoglycan (GAG) side chains endow extracellular matrix proteoglycans with diversity and complexity based upon the length, composition and charge distribution of the polysaccharide chain. Using cultured primary neurons, we show that specific sulfation in the GAG chains of chondroitin sulfate mediates neuronal guidance cues and axonal growth inhibition. Chondroitin-4-sulfate (CS-A), but not chondroitin-6-sulfate (CS-C), exhibits a strong negative guidance cue to mouse cerebellar granule neurons. Enzymatic and gene-based manipulations of 4-sulfation in the GAG side chains alter their ability to direct growing axons. Furthermore, 4-sulfated chondroitin sulfate GAG chains are rapidly and significantly increased in regions that do not support axonal regeneration proximal to spinal cord lesions in mice. Thus, our findings show that specific sulfation along the carbohydrate backbone carries instructions to regulate neuronal function.


The Journal of Neuroscience | 2007

Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans.

Tracy L. Laabs; Hang Wang; Yasuhiro Katagiri; Thomas E. McCann; James W. Fawcett; Herbert M. Geller

Chondroitin sulfate proteoglycans (CSPGs) are upregulated in the CNS after injury and participate in the inhibition of axon regeneration mainly through their glycosaminoglycan (GAG) side chains. In the present study, we have identified a new way to alleviate the inhibition of axonal regeneration by CSPG GAGs. We have successfully decreased the amount of CSPG GAG produced by astrocytes by targeting chondroitin polymerizing factor (ChPF), a key enzyme in the CSPG biosynthetic pathway. Using short interfering RNA (siRNA), we reduced ChPF mRNA levels by 70% in both the Neu7 astrocyte cell line and primary rat astrocytes. This reduction leads to a decrease in ChPF protein levels and a reduced amount of CSPG GAG chains in the conditioned media (CM) of these cells. Secretion of neurocan by primary astrocytes and NG2 core protein by Neu7 cells transfected with ChPF siRNA is not decreased, suggesting that inhibiting GAG chain synthesis does not affect core protein trafficking from these cells. CM from siRNA-treated Neu7 cells is a less repulsive substrate for axons than CM from control cells. In addition, axonal outgrowth from cerebellar granule neurons is increased on or in CM from ChPF siRNA-treated Neu7 cells. These data indicate that targeting the biosynthesis of CSPG GAG is a potentially new therapeutic avenue for decreasing CSPG GAG produced by astrocytes after CNS injury.


Journal of Biological Chemistry | 1998

Nerve growth factor treatment prevents the increase in superoxide produced by epidermal growth factor in PC12 cells.

Edward M. Mills; Kazuyo Takeda; Zu Xi Yu; Victor J. Ferrans; Yasuhiro Katagiri; Hao Jiang; Mark C. Lavigne; Thomas L. Leto; Gordon Guroff

Stimulation of pheochromocytoma (PC12) cells with the mitogen epidermal growth factor (EGF) produced a rapid and robust accumulation of intracellular reactive oxygen species (ROS), an accumulation which, in other systems, has been shown to be essential for mitogenesis. Brief pretreatment of the cells with nerve growth factor (NGF) suppressed the EGF-mediated ROS increase. EGF failed to produce elevations in ROS in a PC12 variant stably expressing a dominant-negative p21 ras construct (PC12-N17) or in cells pretreated with the MEK inhibitor PD098059. NGF failed to suppress the increase in ROS in the PC12 variant nnr5, which lacks p140 trk receptors. The suppression of the increase in ROS by NGF was restored in nnr5 cells stably expressing p140 trk (nnr5-trk), but NGF failed to prevent the increase in ROS in nnr cells expressing mutant p140 trk receptors that lack binding sites for Shc and phospholipase Cγ. Among several inhibitors of superoxide-generating enzymes, only the lipoxygenase inhibitor, nordihydroguaiaretic acid reduced EGF-mediated ROS accumulation. The inhibitory action of NGF on ROS production was mimicked by the nitric oxide donor, sodium nitroprusside, and was blocked by an inhibitor of nitric-oxide synthetase, l-nitroarginine methyl ester. These results suggest a novel mechanism for the rapid interruption of mitogenic signaling by the neurotrophin NGF.


Gene | 1998

SPERMINE IS NOT ESSENTIAL FOR GROWTH OF SACCHAROMYCES CEREVISIAE : IDENTIFICATION OF THE SPE4 GENE (SPERMINE SYNTHASE) AND CHARACTERIZATION OF A SPE4 DELETION MUTANT

Nobuko Hamasaki-Katagiri; Yasuhiro Katagiri; Celia White Tabor; Herbert Tabor

Spermine, ubiquitously present in most organisms, is the final product of the biosynthetic pathway for polyamines and is synthesized from spermidine. In order to investigate the physiological roles of spermine, we identified the SPE4 gene, which codes for spermine synthase, on the right arm of chromosome XII of Saccharomyces cerevisiae and prepared a deletion mutant in this gene. This mutant has neither spermine nor spermine synthase activity. Using the spe4 deletion mutant, we show that S. cerevisiae does not require spermine for growth, even though spermine is normally present in the wild-type organism. This is in striking contrast to the absolute requirement of S. cerevisiae for spermidine for growth, which we had previously reported using a mutant lacking the SPE3 gene (spermidine synthase) [Hamasaki-Katagiri, N., Tabor, C. W., Tabor, H., 1997. Spermidine biosynthesis in Saccharomyces cerevisiae: Polyamine requirement of a null mutant of the SPE3 gene (spermidine synthase). Gene 187, 35-43].


The Journal of Comparative Neurology | 2012

Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice

Jae-Hyuk Yi; Yasuhiro Katagiri; Bala T. S. Susarla; David Figge; Aviva J. Symes; Herbert M. Geller

Chondroitin sulfate proteoglycans (CSPGs) play a pivotal role in many neuronal growth mechanisms including axon guidance and the modulation of repair processes following injury to the spinal cord or brain. Many actions of CSPGs in the central nervous system (CNS) are governed by the specific sulfation pattern on the glycosaminoglycan (GAG) chains attached to CSPG core proteins. To elucidate the role of CSPGs and sulfated GAG chains following traumatic brain injury (TBI), controlled cortical impact injury of mild to moderate severity was performed over the left sensory motor cortex in mice. Using immunoblotting and immunostaining, we found that TBI resulted in an increase in the CSPGs neurocan and NG2 expression in a tight band surrounding the injury core, which overlapped with the presence of 4‐sulfated CS GAGs but not with 6‐sulfated GAGs. This increase was observed as early as 7 days post injury (dpi), and persisted for up to 28 dpi. Labeling with markers against microglia/macrophages, NG2+ cells, fibroblasts, and astrocytes showed that these cells were all localized in the area, suggesting multiple origins of chondroitin‐4‐sulfate increase. TBI also caused a decrease in the expression of aggrecan and phosphacan in the pericontusional cortex with a concomitant reduction in the number of perineuronal nets. In summary, we describe a dual response in CSPGs whereby they may be actively involved in complex repair processes following TBI. J. Comp. Neurol. 520:3295–3313, 2012.


Journal of Neurochemistry | 2011

Smad proteins differentially regulate transforming growth factor‐β‐mediated induction of chondroitin sulfate proteoglycans

Bala T. S. Susarla; Eric D. Laing; Panpan Yu; Yasuhiro Katagiri; Herbert M. Geller; Aviva J. Symes

J. Neurochem. (2011) 119, 868–878.


Journal of Biological Chemistry | 1999

Nerve growth factor (NGF)-induced calcium influx and intracellular calcium mobilization in 3T3 cells expressing NGF receptors

Hao Jiang; Kazuyo Takeda; Philip Lazarovici; Yasuhiro Katagiri; Zu Xi Yu; Geneva Dickens; Alia Chabuk; Xu Wen Liu; Victor J. Ferrans; Gordon Guroff

The neurotrophins have been implicated in the acute regulation of synaptic plasticity. Neurotrophin-stimulated presynaptic calcium uptake appears to play a key role in this process. To understand the mechanism of neurotrophin-stimulated calcium uptake, the regulation of calcium uptake and intracellular mobilization by nerve growth factor (NGF) was investigated using NIH 3T3 cells stably transfected with either the high affinity NGF receptor p140 trk (3T3-Trk) or the low affinity NGF receptor p75NGFR(3T3-p75). In 3T3-Trk cells, NGF increased both calcium uptake and intracellular calcium mobilization. In 3T3-p75 cells, NGF increased calcium uptake but not intracellular calcium mobilization. K-252a alone increased intracellular calcium in 3T3-Trk cells but not in 3T3-p75 cells. Nifedipine, an inhibitor of calcium uptake throughl-type calcium channels, inhibited the action of NGF on both 3T3-Trk cells and 3T3-p75 cells, indicating that both p140 trk and p75NGFR receptors are linked to nifedipine-sensitive l-type calcium channels. These studies show that either NGF receptor will support increases in intracellular calcium but that p140 trk does so by increasing both uptake and mobilization, whereas p75NGFR does so by increasing uptake only.


Journal of Neurochemistry | 2001

Delayed and Sustained Activation of p42/p44 Mitogen-Activated Protein Kinase Induced by Proteasome Inhibitors Through p21ras in PC12 Cells

Keiko Hashimoto; Gordon Guroff; Yasuhiro Katagiri

Abstract: Proteolysis by the ubiquitin/proteasome pathway regulates the intracellular level of several proteins, some of which control cell proliferation and cell cycle progression. To determine what kinds of signaling cascades are activated or inhibited by proteasome inhibition, we treated PC12 cells with specific proteasome inhibitors and subsequently performed in‐gel kinase assays. N‐Acetyl‐Leu‐Leu‐norleucinal and lactacystin, which inhibit the activity of the proteasome, induced the activation of p42/p44 mitogen‐activated protein (MAP) kinases [extracellular signal‐regulated kinases (ERKs) 1 and 2]. In contrast, N‐acetyl‐Leu‐Leu‐methional, which inhibits the activity of calpains, but not of the proteasome, failed to induce ERK activation. Uniquely, the kinetics of MAP kinase activation induced by proteasome inhibitors are very slow compared with those resulting from activation by nerve growth factor; ERK activation is detectable only after a 5‐h treatment with the inhibitors, and its activity remained unchanged for at least until 27 h. Proteasome inhibitor‐initiated ERK activation is inhibited by pretreatment with the ERK kinase inhibitor PD 98059, as well as by overexpression of a dominant‐negative form of Ras. Thus, proteasome inhibitors induce sustained ERK activation in a Ras‐dependent manner. Proteasome inhibitor‐induced neurite outgrowth, however, is not inhibited by PD 98059, indicating that sustained activation of ERKs is not the factor responsible for proteasome inhibitor‐induced morphological differentiation. Our data suggest the presence of a novel mechanism for activation of the MAP kinase cascade that involves proteasome activity.

Collaboration


Dive into the Yasuhiro Katagiri's collaboration.

Top Co-Authors

Avatar

Herbert M. Geller

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Panpan Yu

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Gordon Guroff

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Aviva J. Symes

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Hao Jiang

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Eric D. Laing

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Hang Wang

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Kazuyo Takeda

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Makoto Shibutani

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Nathanael J. Bangayan

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge